ChartRow logo
Share this page
MIRM
$80.14-2.73%
as of close, Oct 16, 2026
☾ AH $80.14 -2.73%
PeersMRNALLYMDTUNHJNJTMO

Mirum Pharmaceuticals Inc. trailing returns

How Mirum Pharmaceuticals Inc. (MIRM) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-2.7%+0.0%-2.7%—
5 days-6.8%+0.0%-6.8%-7.5%Oct 13
1 month-17.7%+0.0%-17.7%-19.8%Oct 6
YTD+1.5%+0.0%+1.5%-38.4%Oct 6
1 year+7.7%+0.0%+7.7%-38.4%Oct 2026
5 years+36.2%+0.0%+36.2%+368.1%-40.3%Dec 2022
Since inception (2019)+28.2%+0.0%+28.2%+506.7%-63.8%Mar 2020

Growth of MIRM#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+36.2%/year · +368.1%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in MIRM's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Mirum Pharmaceuticals Inc.'s return since inception?
Since 2019, Mirum Pharmaceuticals Inc. (MIRM) has compounded at about +28.2% a year — +506.7% in total.

More on Mirum Pharmaceuticals Inc.